Floatz logo

Adezunap

Back Pain

Apurano Pharmaceuticals GmbHPhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

11 Active assets in the Back Pain cohort.

Asset / SponsorPhaseRating
Oxycodone
Grünenthal GmbH
Phase 4BBB
NEPENTHE
MedtronicNeuro
Phase 4BB
LIDOCAINE
Medical College of Wisconsin
Phase 4BB
Bxcl501
Medical College of Wisconsin
Phase 4BB
PROPOFOL
Medical College of Wisconsin
Phase 4BB

View all 41 →

Same molecule, other indications

Adezunap is also rated in:

Post Operative PainDormant
B
Indicative ·
60 / 100
View asset →
Pain SyndromeDormant
B
Indicative ·
60 / 100
View asset →
Central Neuropathic PainDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →